Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Angina Market Size Shifted, And What Is the Outlook Through 2034?
The market size of angina has seen significant expansion lately. It’s forecasted to rise from $10.71 billion in 2024 to $11.36 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this historical growth include a rise in the occurrence of coronary heart disease, escalated usage of vasodilators, an increasing incidence of myocardial ischemia, enhancements in diagnostic methods, and an uptick in the implementation of imaging techniques.
Expectations are high for the angina market to experience considerable growth in the coming years. It’s projected to amass to$14.18 billion by 2029, with a compound annual growth rate (CAGR) of 5.7%. This forecasted growth can be linked to the rising prevalence of chronic angina pectoris, an increase in drug approvals and clinical research, a growing demand from retail pharmacies, increased cardiovascular health awareness, and an ever-growing need for medication. The forecast period will see trends like technological leaps in early diagnosis, improved procedures in angioplasty and stenting, novel gene therapy methods, a rising demand for coronary stents, and progress in treating coronary artery disease.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp
What are the Fundamental Drivers and Innovations Shaping the Angina Market?
The upward trend in coronary artery disease occurrences is anticipated to augment the expansion of the angina market in the future. Coronary artery disease (CAD), also referred to as coronary heart disease (CHD) or ischemic heart disease (IHD), is a medical condition where the coronary arteries, which provide blood, oxygen, and nutrients to the heart muscle, become narrowed or blocked. The surge in instances of coronary artery disease is attributed to shifts in lifestyle habits, environmental influences, and genetic components. Angina holds a vital function in detecting and studying the widespread presence of coronary artery disease. Its detection paves the way for medical assessment and diagnosis, aids in risk stratification, influences treatment approaches, and guides public health initiatives. For instance, the American Heart Association revealed in January 2023 that the population of adults living with CAD in the U.S. escalated from 18.2 million to an estimated 19.3 million between 2021 and 2022. Consequently, the mounting instances of coronary artery diseases act as a catalyst for the growth of the angina market.
How Is the Angina Market Segmented?
The anginamarket covered in this report is segmented –
1) By Type: Angina Pectoris; Unstable Angina; Prinzmetal Angina; Other Types
2) By Treatment: Lifestyle Changes; Medications; Angioplasty And Stenting; Coronary Bypass Surgery; Other Treatments
3) By Drug Class: Beta Blockers; Nitrates And Calcium Channel Blockers; Angiotensin-Converting Enzyme Inhibitors; Other Drug Classes
4) By Application: Clinics; Hospitals; Other Applications
Subsegments:
1) By Angina Pectoris: Stable Angina; Chronic Stable Angina; Effort-Induced Angina; Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina; Pre-Infarction Angina; Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina; Coronary Artery Spasm-Induced Angina; Variant Angina
4) By Other Types: Nocturnal Angina; Post-Infarction Angina; Angina With Silent Myocardial Ischemia; Angina Due To Aortic Stenosis Or Valve Disease
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp
Which Regions Are Driving the Next Phase of the Angina Market Growth?
North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Angina Market?
Leading firms in the angina market are focusing on the creation of innovative medicines such as metoprolol tartrate tablets, aiming to improve the treatment of conditions associated with coronary artery disease (CAD) like angina. Metoprolol tartrate is a widely prescribed medication for diverse cardiovascular conditions including angina, hypertension, and heart failure. For instance, in April 2023, the India-based pharmaceutical entity, Zydus, got the green light from the United States Food and Drug Administration (US-FDA) to produce and distribute its generic equivalent of Metoprolol Tartrate Tablets USP with potencies of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is utilized for managing several cardiovascular issues, mainly high blood pressure and angina and to enhance survival rates post heart attack.
View the full report here:
https://www.thebusinessresearchcompany.com/report/angina-global-market-report
How Is the Angina Market Defined and What Are Its Core Parameters?
Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model